See what we’ve been up to.
Vivian EVP initiative identifies People, Purpose and Trust as key drivers of employee engagement
July 2026
Pharmaceutical and wellbeing company Vivian has completed a comprehensive Employee Value Proposition (EVP) initiative involving nearly all of the company’s 53 employees, revealing that people, purpose and trust are the qualities that matter the most for its employees.
Vivian Announces Partnership with Novartis Pharma Services AG in Malta
January 2026
Vivian has entered into a distribution agreement with worldwide R&D pharmaceutical company Novartis Pharma Services AG, a move that continues to reflect Vivian’s established reputation as a trusted partner for global life sciences brands.
Employee of the Year 2025 – Melchior Pace
December 2025
At Vivian’s annual Christmas celebration, Melchior Pace was named Employee of the Year; the company’s most coveted award and an honour that, by his own admission, took a few seconds to fully sink in.
Melchior had been part of Vivian for the past seventeen years, leading the company’s technical division responsible for the supply and servicing of laboratory equipment and medical devices.
Vivian Announces Representation of LEO Pharma
October 2025
Partnership Brings Specialist Dermatology Treatments to Malta
Vivian has partnered with global dermatology leader LEO Pharma to bring advanced skin treatments to Maltese patients, improving access to therapies for chronic conditions such as psoriasis and eczema.
This agreement enables Vivian to distribute LEO Pharma’s dermatology portfolio in Malta, namely a portfolio of innovative therapies for chronic skin conditions that affect thousands of Maltese patients and can significantly impact quality of life.
Psoriasis, a dry and scaly skin condition, affects around 5.1 million Europeans and approximately 5% of Malta’s population. Eczema, characterised by rashes, redness, inflammation, and dry skin, affects 10–15% of Maltese children and about 5% of adults.
Emerging Trends in Aesthetic Medicine Take Centre Stage as Vivian Prepares SKINVIVE Launch in Malta
October 2025
The global aesthetic medicine industry is undergoing a significant transformation, with a shift towards treatments that prioritise natural results, patient-specific solutions, and the integration of overall health and wellness.
Regenerative approaches are gaining traction for their ability to stimulate collagen production and improve skin health at a cellular level, offering subtle, longer-lasting results.
Global Endometriosis Expert Headlines Launch of Groundbreaking New Treatment for Women in Malta
July 2025
A recent wave of national awareness and deeply personal stories in the media made the conversation around endometriosis in Malta louder and more urgent. Now, in a breakthrough development, local wellness and pharmaceutical leader Vivian has launched a new oral treatment for women suffering from this chronic and often misunderstood condition.
The launch of this new treatment was addressed by internationally acclaimed endometriosis specialist, Prof. Jacques Donnez, a renowned Belgian gynaecologist and recently, the recipient of the Endometriosis Foundation of America’s prestigious Harry Reich Award.
New Medically Supported Treatment for Obesity in Malta
June 2025
Vivian has launched a new prescription-based treatment in Malta aimed at supporting individuals living with obesity, one of the country’s most urgent health challenges. This new treatment marks a significant step in broadening the range of tools available to healthcare professionals and patients seeking a medically supervised, personalised approach to weight management.
Pharma Market Access: Regulatory Affairs and Quality in Pharma
June 2025
The pharmaceutical industry is often associated with innovation, research, and commercial strategy. The industry, however, also acts as an effective gatekeeper of patient access, ensuring that medicines are not only effective but also lawful, traceable, and safe.
Robust Financial Performance Supporting Vivian’s Drive For Digital Innovation in Healthcare Logistics
May 2025
Founded over 73 years ago as a family-run business, Vivian has grown into a recognised leader in Malta’s healthcare sector. Amidst increasing competition and stricter regulatory requirements, the company remains focused on advancing local healthcare.
Vivian Launches 2025 with Mental Health at the Forefront
March 13, 2025
Collaborates with Richmond Foundation to Prioritise Employee Well-Being
Burnout, anxiety, and low motivation are three common factors that undermine employees’ mental health, impacting both workplace productivity and individual well-being. Yet, despite greater awareness, many employees remain unaware of what constitutes poor mental well-being and how to address it effectively.
Vivian Strengthens Leadership Team With Three Major Management Roles
January 2025
Vivian continues to assert its industry leadership in the healthcare industry with three strategic appointments that underline the company’s commitment to workforce investment and industry growth.
Melchior Pace has been appointed as Head of Technology, Daniela Magro as Sales & Business Development Manager of Vivian’s Women’s Health Unit and newcomer Steven Ellul has been appointed Head of Sales & Business Development.
Celebrating Excellence: Vivian’s Employees of the Year 2024
December 2024
For 2024’s coveted ‘Employee of the Year’ award, Vivian’s board was unanimous – two employees deserved to be awarded for they both showed the same hard work, dedication, and outstanding contributions. They are Daniela Grech and Charlon Ellul.
Vivian Leads Inclusion Of New Breast Cancer Treatment
October 2024
As Pink October brings breast cancer awareness to the forefront, Vivian has taken a monumental step by securing a new drug in the treatment of breast cancer on Malta’s national formulary, giving Maltese patients broader access to this vital therapy, which had previously been available only privately.
EENergy Project 2024
August 2024
No better way to celebrate our first year in the new offices in Marsa than by announcing that we have confirmed financial support from the EENergy project (Enterprise Europe Network Energy grants for European SMEs) for our new roof-top solar panel system – a renewable energy project to help us operate with more energy efficiency.
VIVIAN ONE OF FIRST SIGNATORIES OF THE MALTA DIVERSITY & INCLUSION CHARTER
May 2024
A workplace where all employees are and feel valued, respected and integrated, a commitment to diversity and inclusion through the support of community initiatives and programs, the support for employees from under-represented groups with mentors and sponsors to advance in their careers
Vivian MediTech
Division rebranding from LEMD to MediTech
January 2024
In an era of constant advancements in healthcare technology, adaptability is key for any organization striving for success. With this in mind, we are thrilled to announce the transformation of our division from a Laboratory Equipment and Medical Devices Unit to Vivian MediTech. This rebranding embodies our commitment to pioneering innovation, staying ahead of the curve, and meeting the evolving needs of the healthcare industry.
Vivian Launches The Vivian Academy
Empowering Society Through More Informed Healthcare
5th April 2023
Having just commemorated its 70th anniversary, leading healthcare company VIVIAN established a new concept, rooted in decades of expertise, experience and a strong professional network. “Vivian Academy is all about empowerment; empowering our own people, our partners in the industry, our stakeholders and our wider communities for more informed healthcare,” say HANNAH CREMONA, strategic lead advisor of this project and YAN GRIMA, General Manager at Vivian.
DEVICARE LAUNCH – FEBRUARY 2023
February 2023
When it comes to kidney stones, Malta is facing several challenges namely limited stone analysis with only qualitative data available, the fact that certain tests are still being conducted abroad, that there is a lack of data related to epidemiology, genetics, and admissions as well as already very busy nephrology and urology clinics. Coupled with all this, there is also a general lack of awareness on this condition and how to avoid it.
